Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Negative regulation of intracellular hepatitis C virus replication by interferon regulatory factor 3.

Yamashiro T, Sakamoto N, Kurosaki M, Kanazawa N, Tanabe Y, Nakagawa M, Chen CH, Itsui Y, Koyama T, Takeda Y, Maekawa S, Enomoto N, Sakugawa H, Watanabe M.

J Gastroenterol. 2006 Aug;41(8):750-7.

PMID:
16988763
2.

Regulation of hepatitis C virus replication by interferon regulatory factor 1.

Kanazawa N, Kurosaki M, Sakamoto N, Enomoto N, Itsui Y, Yamashiro T, Tanabe Y, Maekawa S, Nakagawa M, Chen CH, Kakinuma S, Oshima S, Nakamura T, Kato T, Wakita T, Watanabe M.

J Virol. 2004 Sep;78(18):9713-20.

3.

Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.

Nandakumar R, Finsterbusch K, Lipps C, Neumann B, Grashoff M, Nair S, Hochnadel I, Lienenklaus S, Wappler I, Steinmann E, Hauser H, Pietschmann T, Kröger A.

Gastroenterology. 2013 Dec;145(6):1414-23.e1. doi: 10.1053/j.gastro.2013.08.037. Epub 2013 Aug 21.

PMID:
23973921
4.

Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.

Itsui Y, Sakamoto N, Kurosaki M, Kanazawa N, Tanabe Y, Koyama T, Takeda Y, Nakagawa M, Kakinuma S, Sekine Y, Maekawa S, Enomoto N, Watanabe M.

J Viral Hepat. 2006 Oct;13(10):690-700.

PMID:
16970601
5.

Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.

Horscroft N, Bellows D, Ansari I, Lai VC, Dempsey S, Liang D, Donis R, Zhong W, Hong Z.

J Virol. 2005 Mar;79(5):2788-96.

6.

Activation of interferon-stimulated response element in huh-7 cells replicating hepatitis C virus subgenomic RNA.

Pai M, Prabhu R, Panebra A, Nangle S, Haque S, Bastian F, Garry R, Agrawal K, Goodbourn S, Dash S.

Intervirology. 2005;48(5):301-11.

PMID:
15956798
7.

Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes.

Cheng X, Gao XC, Wang JP, Yang XY, Wang Y, Li BS, Kang FB, Li HJ, Nan YM, Sun DX.

World J Gastroenterol. 2014 Dec 28;20(48):18284-95. doi: 10.3748/wjg.v20.i48.18284.

8.

Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.

Chang JH, Kato N, Muroyama R, Taniguchi H, Guleng B, Dharel N, Shao RX, Tateishi K, Jazag A, Kawabe T, Omata M.

Liver Int. 2010 Feb;30(2):311-8. doi: 10.1111/j.1478-3231.2009.02144.x. Epub 2009 Oct 16.

PMID:
19840259
9.

Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.

Plumlee CR, Lazaro CA, Fausto N, Polyak SJ.

Virol J. 2005 Dec 2;2:89.

11.

Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.

Zhang T, Lin RT, Li Y, Douglas SD, Maxcey C, Ho C, Lai JP, Wang YJ, Wan Q, Ho WZ.

Hepatology. 2005 Oct;42(4):819-27.

PMID:
16175599
12.

Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122.

Lin LT, Noyce RS, Pham TN, Wilson JA, Sisson GR, Michalak TI, Mossman KL, Richardson CD.

J Virol. 2010 Sep;84(18):9170-80. doi: 10.1128/JVI.00559-10. Epub 2010 Jun 30.

13.

Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy.

Binder M, Kochs G, Bartenschlager R, Lohmann V.

Hepatology. 2007 Nov;46(5):1365-74.

PMID:
17668876
14.

Regulation of PKR and IRF-1 during hepatitis C virus RNA replication.

Pflugheber J, Fredericksen B, Sumpter R Jr, Wang C, Ware F, Sodora DL, Gale M Jr.

Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4650-5. Epub 2002 Mar 19.

15.

Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells.

Yao L, Yan X, Dong H, Nelson DR, Liu C, Li X.

Virol J. 2011 Sep 21;8:445. doi: 10.1186/1743-422X-8-445.

16.
17.

Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.

Dharel N, Kato N, Muroyama R, Taniguchi H, Otsuka M, Wang Y, Jazag A, Shao RX, Chang JH, Adler MK, Kawabe T, Omata M.

Hepatology. 2008 Apr;47(4):1136-49. doi: 10.1002/hep.22176.

PMID:
18220274
18.

Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.

Tanabe Y, Sakamoto N, Enomoto N, Kurosaki M, Ueda E, Maekawa S, Yamashiro T, Nakagawa M, Chen CH, Kanazawa N, Kakinuma S, Watanabe M.

J Infect Dis. 2004 Apr 1;189(7):1129-39. Epub 2004 Mar 16.

PMID:
15031779
19.

Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy.

Mizui T, Yamashina S, Tanida I, Takei Y, Ueno T, Sakamoto N, Ikejima K, Kitamura T, Enomoto N, Sakai T, Kominami E, Watanabe S.

J Gastroenterol. 2010 Feb;45(2):195-203. doi: 10.1007/s00535-009-0132-9. Epub 2009 Sep 17.

PMID:
19760134
20.

Activation of the interferon-beta promoter during hepatitis C virus RNA replication.

Fredericksen B, Akkaraju GR, Foy E, Wang C, Pflugheber J, Chen ZJ, Gale M Jr.

Viral Immunol. 2002;15(1):29-40.

PMID:
11952144

Supplemental Content

Support Center